MicroRNA miR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 2830 views | HTML 3323 views | ?
Vinayakumar Siragam1,4,* Zina Jeyapalan Rutnam1,4,*, Weining Yang2, Ling Fang1,4, Linlin Luo2, Xiangling Yang1,4, Minhui Li1,4, Zhaoqun Deng1,4, Jun Qian3, Chun Peng2, and Burton B. Yang1,4
1 Sunnybrook Research Institute, Sunnybrook Health Sciences Centre
2 Departments of Biology, York University
3 The Affiliated People’s Hospital of Jiangsu University, Zhenjiang City, China
4 Department of Laboratory Medicine and Pathobiology, University of Toronto
* denotes equal contribution
Burton B. Yang, email:
Keywords: microRNA, miR-98, angiogenesis, tumorigenesis, invasion
Received: October 22, 2012, Accepted: November 02, 2012, Published: November 06, 2012
Angiogenesis and invasion are essential processes for solid tumor growth and dissemination. The tumor development process can be dependent on the activation of a series of signaling pathways, including growth factor-activated pathways. MicroRNAs have been shown to be critical for tumorigenesis, but their roles in cancer angiogenesis, invasion and other signaling pathways important for tumor development are still unclear in the context of tumor biology. We investigated the role of microRNA miR-98 in regulating tumor growth, invasion, and angiogenesis using a highly aggressive breast cancer model in vitro and in vitro. We found that the expression of miR-98 inhibited breast cancer cell proliferation, survival, tumor growth, invasion, and angiogenesis. Conversely, inhibition of endogenous miR-98 promoted cell proliferation, survival, tumor growth, invasion, and angiogenesis. It appeared that miR-98 inhibited angiogenesis by modulating endothelial cell activities including cell spreading, cell invasion and tubule formation. Interestingly, miR-98 reduced the expression of ALK4 and MMP11, both of which were potential targets of miR-98. Transfection of an anti-miR-98 construct increased the expression of both targets. We confirmed that mir-98 targeted the 3’-untranslated regions of ALK4 and MMP11. Finally, ALK4- and MMP11-specific siRNAs inhibited breast cancer cell proliferation, survival, and angiogenesis. Rescue experiments with ALK4 and MMP11 constructs reversed the anti-proliferative, anti-invasive and anti-angiogenic effects of miR-98. Our findings define a regulatory role of miR-98 in tumor angiogenesis and invasion through repressed ALK4 and MMP11 expression.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.